← Back to all earnings calls

Avalo Therapeutics, Inc. Q2 FY2020 Earnings Call

Avalo Therapeutics, Inc. (AVTX)

Earnings Call FY2020 Q2 Call date: 2020-08-06 Concluded

Share

Quarter scorecard

Revenue

$1.34M

-3.9% YoY

Net income

$

Revenue · products & services

Product $1.34M

License $

Documents & deck